Amy Edwards, MD, is a physician in the Division of Pediatric Infectious Diseases and Rheumatology and a hospitalist at University Hospitals Rainbow Babies & Children’s Hospital . She also is a staff physician at St. John Medical Center Rainbow Rapid Care, Westlake, Ohio, and Assistant Professor, Pediatrics, Case Western Reserve University School of Medicine.
Dr. Edwards is board certified in pediatrics and pediatric infectious diseases. She has a special interest in pediatric infectious diseases, and she joined the UH Rainbow Babies & Children's Hospital staff in 2013
She earned her undergraduate degree from Georgia Institute of Technology, Atlanta, Ga., and a doctorate in medicine from Ben Gurion University of the Negev Medical School for International Health, Beer Sheva, Israel. Dr. Edwards completed her residency in pediatrics at MetroHealth Medical Center, Cleveland, Ohio, and a fellowship in pediatric infectious diseases at UH Rainbow Babies & Children's Hospital. As a fellow she traveled on medical missions trips to underserved people in Ethiopia and Bolivia.
Dr. Edwards currently is co-investigator on a study of Rift Valley Fever virus in Africa and the Arabian peninsula with the Case Western Reserve University Center for Global Health and a UH Rainbow Babies & Children’s Hospital study on the risk of renal failure in children treated with vancomycin.
She is a member of the American Academy of Pediatrics, Infectious Diseases Society of America and Pediatric Infectious Diseases Society.
Infectious diseases in underserved pediatric populations
Coomplications of antibiotic treatment in children
Patient Satisfaction Reviews
0 out of 5
- Pediatric Infectious Diseases - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Uh Rainbow Babies And Children's Hospital (2010 - 2013)
Residency | Pediatrics
Pediatrics - Metrohealth Medical Center (2007 - 2010)
Ben-Gurion University Of The Negev (2007)
Georgia Institute Of Technology (2001)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Amy Marie Edwards did not disclose any Outside Relationships with Industry.